Showing results (201-210 of 306) with videos related to

Sort By:
Pageof 31
Translational Neuroscience|July 7, 2022
A patient with hereditary transthyretin amyloidosis involving multiple cranial nerves due to a rare p.(Phe84Ser) variantXian-Rang Yan, Ming-Fan Hong, Zhi-Hua Zhou, et al.
Acta Pharmacologica Sinica|December 1, 2021
Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart diseaseYang-Yang He, Yi Yan, Ji-Wang Chen, et al.
The Lancet. Respiratory Medicine|April 13, 2016
Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trialHossein-Ardeschir Ghofrani, Friedrich Grimminger, Ekkehard Grünig, et al.
BMJ Open|February 9, 2022
Non-linear relationship between basal serum albumin concentration and cardiac arrest in critically ill patients with end-stage renal disease: a cross-sectional studyYong-Qin Zeng, Zuo-An Qin, Zi-Wei Guo, et al.
International Journal of Cardiology|August 10, 2016
Optical coherence tomography for hypertensive pulmonary vasculatureXin Jiang, Fu-Hua Peng, Qian-Qian Liu, et al.
Chest|May 15, 2013
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trialVictor F Tapson, Zhi-Cheng Jing, Kai-Feng Xu, et al.
Stem Cell Research|November 22, 2020
Generation of an induced pluripotent stem cell line (PUMCHi006-A) derived from a patient with pulmonary arterial hypertension carrying heterozygous c.1339 G > A mutation in PTGIS geneYong-Jian Zhu, Si-Jin Zhang, Xiao-Han Wu, et al.
Clinical Cardiology|March 1, 2017
Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertensionQin-Hua Zhao, Lan Wang, Bigyan Pudasaini, et al.
Pulmonary Therapy|November 9, 2024
Long-Term Safety and Efficacy of Macitentan in Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from MERIT and its Open-Label ExtensionNick H Kim, Andrea M D'Armini, Luke S Howard, et al.
Medicine|November 13, 2024
Differential effect on labor force health initiated by the first wave of the COVID-19 in TaiwanLi-Chen Yen, Sui-Lung Su, Meng-Chang Lee, et al.
Pageof 31